Big Move For Myovant Sciences Ltd.
Myovant Sciences Ltd. (MYOV:NYSE) soared at $24.44, a gain of 36.1%. On Mon, Oct 03, 2022, MYOV:NYSE touched a New 2-Week High of $24.44. The stock appeared on our News Catalysts scanner on Mon, Oct 03, 2022 at 04:40 PM in the 'MISCELLANEOUS' category. From Mon, Sep 19, 2022, the stock recorded 50.00% Up Days and 54.55% Green Days
About Myovant Sciences Ltd. (MYOV:NYSE)
Myovant Sciences Ltd is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing therapies for women's health diseases and other endocrine-related disorders. Its product candidate is relugolix.
Top 10 Gainers:
- LogicBio Therapeutics, Inc. (LOGC:NASDAQ), 637.61%
- FedNat Holding Company (FNHC:NASDAQ), 308.7%
- Oblong Inc. (OBLG:NASDAQ), 167.02%
- Wearable Devices Ltd. (WLDS:NASDAQ), 48.86%
- Flexible Solutions International Inc. (FSI:NYSEMKT), 44.24%
- Myovant Sciences Ltd. (MYOV:NYSE), 36.08%
- Lottery.com Inc. (LTRY:NASDAQ), 34%
- LiveWire Group Inc. (LVWR:NYSE), 29.53%
- Engine Gaming and Media Inc. (GAME:NASDAQ), 28.87%
- Viasat, Inc. (VSAT:NASDAQ), 26.93%